GB Sciences, Inc.
GBLX
$0.00
$0.000.00%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 47.30% | 33.16% | 38.97% | -149.33% | 56.86% |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -100.00% | -30.97% |
| Total Other Non-Cash Items | -- | -- | -- | 100.00% | -437.97% |
| Change in Net Operating Assets | -128.86% | -68.52% | 22.55% | 281.85% | 154.30% |
| Cash from Operations | -15.41% | -389.55% | 91.29% | -22.93% | 50.21% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -100.00% | -63.83% |
| Cash from Investing | -- | -- | -- | -100.00% | -63.83% |
| Total Debt Issued | 13.64% | -- | -- | -- | -100.00% |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -100.00% | -- | -- | -84.88% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | 100.00% |
| Cash from Financing | 13.64% | 1,000.00% | -95.95% | 641.74% | -86.81% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -69.57% | 119.17% | -118.18% | 93.69% | -216.29% |